DF

DecisionPoint Financial Portfolio holdings

AUM $429M
1-Year Est. Return 9.45%
This Quarter Est. Return
1 Year Est. Return
+9.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$429M
AUM Growth
+$37.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
678
New
Increased
Reduced
Closed

Top Sells

1 +$1.06M
2 +$922K
3 +$378K
4
META icon
Meta Platforms (Facebook)
META
+$371K
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$357K

Sector Composition

1 Financials 4.6%
2 Technology 1.8%
3 Consumer Discretionary 0.6%
4 Industrials 0.29%
5 Communication Services 0.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SONY icon
176
Sony
SONY
$170B
$4.6K ﹤0.01%
160
MA icon
177
Mastercard
MA
$497B
$4.59K ﹤0.01%
8
CVS icon
178
CVS Health
CVS
$95.2B
$4.46K ﹤0.01%
58
PHYS icon
179
Sprott Physical Gold
PHYS
$15.5B
$4.45K ﹤0.01%
150
ISRG icon
180
Intuitive Surgical
ISRG
$202B
$4.38K ﹤0.01%
10
SYK icon
181
Stryker
SYK
$140B
$4.37K ﹤0.01%
12
COR icon
182
Cencora
COR
$65B
$4.37K ﹤0.01%
14
SDY icon
183
State Street SPDR S&P Dividend ETF
SDY
$20.1B
$4.2K ﹤0.01%
30
-108
CM icon
184
Canadian Imperial Bank of Commerce
CM
$80.7B
$4.18K ﹤0.01%
52
PDBC icon
185
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$4.6B
$4.13K ﹤0.01%
308
ASML icon
186
ASML
ASML
$443B
$4.01K ﹤0.01%
4
WMT icon
187
Walmart
WMT
$912B
$3.98K ﹤0.01%
39
IXJ icon
188
iShares Global Healthcare ETF
IXJ
$4.46B
$3.94K ﹤0.01%
+43
NVO icon
189
Novo Nordisk
NVO
$211B
$3.91K ﹤0.01%
66
LRN icon
190
Stride
LRN
$2.68B
$3.9K ﹤0.01%
27
BAR icon
191
GraniteShares Gold Shares
BAR
$1.41B
$3.89K ﹤0.01%
+102
PM icon
192
Philip Morris
PM
$236B
$3.86K ﹤0.01%
24
TMO icon
193
Thermo Fisher Scientific
TMO
$218B
$3.72K ﹤0.01%
7
COST icon
194
Costco
COST
$409B
$3.67K ﹤0.01%
4
VRTX icon
195
Vertex Pharmaceuticals
VRTX
$118B
$3.64K ﹤0.01%
9
DQ
196
Daqo New Energy
DQ
$2.17B
$3.63K ﹤0.01%
125
GE icon
197
GE Aerospace
GE
$304B
$3.61K ﹤0.01%
12
AMAT icon
198
Applied Materials
AMAT
$214B
$3.48K ﹤0.01%
16
NVS icon
199
Novartis
NVS
$257B
$3.29K ﹤0.01%
+25
AMGN icon
200
Amgen
AMGN
$186B
$3.28K ﹤0.01%
11